Generated by AI
Summary of Aug 14's posts. Generated by AI.
Summary of Aug 14's posts. Generated by AI.
Summary of Apr 2's posts. Generated by AI.
Summary of Aug 14's posts. Generated by AI.
Investors talking about MGRX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
Mangoceuticals, Inc. is a healthcare company focused on men’s wellness products and services delivered through a telemedicine platform. The company develops, markets, and sells a range of branded offerings that address erectile dysfunction, hair loss, hormone balance and therapy, and weight loss, alongside related online consultations and pharmacy fulfillment services. Its product portfolio includes Mango, Grow, Mojo, and Slim, which are designed for direct-to-consumer access through digital health channels. Mangoceuticals also provides prescribed medications through licensed pharmacy partners as part of its telehealth model, connecting patients with healthcare professionals for online care. Based in Dallas, Texas, and founded in 2021, Mangoceuticals operates in the healthcare services market with a focus on accessible, digitally enabled wellness solutions.
Website17130 N. Dallas Parkway
Dallas, TX, 75248
United States
The latest articles about MGRX.
U.S. stock futures rose, while Nike plunged 9.5% after missing revenue estimates. Roze AI, Mangoceuticals and other stocks also fell premarket.
Mangoceuticals shares fall 12% after hours despite a $2.5 million strategic investment in its antiviral IP subsidiary.